Importantly, our findings correspond well to results showing negative prognostic value of a decreased expression of HSPA1 in small cell lung carcinoma25, or association between a high level of HSPA1 and longer disease-free survival of NSCLC patients who received adjuvant platinum-based chemotherapy26. This evidence concerns the gene HSPA1A and non-small cell lung carcinoma.